Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Choosing points over cash rebates can lead to greater rewards, especially for travel enthusiasts. Find out why this option is beneficial.
27,389 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
As the EV market accelerates, some memory-faded battery names may offer outsized upside. This article dives into how ...
A decade can dramatically change a portfolio. This article explores how you'd invested $10,000 Walmart ten years ago ...
Chasing Nvidia’s AI-driven rally is tempting, but utility stocks offer stable dividends, growth through grid moderniz...
Rigetti Computing lives at the edge of technology and finance. This article breaks down the revenue puzzle, the risks...
A Global Partners LP COO sold nearly $740k worth of units in a short window. This article explains what insider trade...
A high-stakes earnings year and a single insider trade create a nuanced picture for ANI Pharmaceuticals. This guide b...
Tech stocks grab headlines, but a smart shift toward dividend-focused value can offer resilience and growth. Learn wh...
In today’s market briefing, Opendoor climbs as it nears a Russell 3000 inclusion, while broader indices tread water. ...
This high-flying semiconductor stock has captured investors’ attention with AI-driven growth. It offers strong upside...
Arista Networks stock flew higher on Friday, climbing more than 4% on a fresh analyst upgrade. This article breaks do...